It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | ActiveRmanirex Pharma Private Limited, a active private limited company, was established on 07 August 2020 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TG2020PTC142591. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.82 M.
Its leadership includes Konduru Sandhya (Additional Director), Maniraju Ravulapalli (Director). Past directors included Ramya Polina, Tejaswini Putti, Konduru Subbarama Raju. It holds ₹1.39 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1-8-720/1/3, Part Portion Of First Floor,Room No 3 Near Axis Bank, Vidyanagar, Hyderabad, Telangana, 500044.
U51909TG2020PTC142591
142591
07 August 2020
₹1.00 M
₹0.82 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rmanirex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Konduru Sandhya | Additional Director | 14 Jan 2021 | Current |
| Maniraju Ravulapalli | Director | 07 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 01 Dec 2023 | Past |
| Pramod Abcsdd | Director | 10 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rmanirex Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 901.62% increase. The company also saw a substantial improvement in profitability, with a 134.33% increase in profit. The company's net worth Soared by an impressive increase of 7637.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Rmanirex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,386,951.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2025 | Hdfc Bank Limited | ₹0.73 M | Open |
| 10 Oct 2022 | Hdfc Bank Limited | ₹0.66 M | Open |
Explore comprehensive loan charge details -
Rmanirex Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rmanirex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rmanirex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 0.73 M with Charge ID 101141197 was registered on 02 Jun 2025. was recorded as a recent event.
Rmanirex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Rmanirex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.66 M with Charge ID 100678552 was registered on 10 Oct 2022. was recorded as a recent event.
Progress on Konduru Sandhya was appointed as a Additional Director was appointed as a Additional Director on 14 Jan 2021 & has been associated with this company since 4 years 11 months . was documented.
Progress on Maniraju Ravulapalli was appointed as a Director was appointed as a Director on 07 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
The CIN of Rmanirex Pharma Private Limited is U51909TG2020PTC142591.
Rmanirex Pharma Private Limited is headquartered at 1-8-720/1/3, Part Portion Of First Floor,Room No 3 Near Axis Bank, Vidyanagar, Hyderabad, Telangana, 500044.
Rmanirex Pharma Private Limited was incorporated on 07 August 2020.
The current directors of Rmanirex Pharma Private Limited are
The primary industry of Rmanirex Pharma Private Limited is Trade.
Rmanirex Pharma Private Limited is unlisted.
The authorized capital of Rmanirex Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.82 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX